To know the Efficacy of the drugs Deflazacort and Tamsulosin in Kidney stone Clearance after Stone Breakage by Shock method.

Evaluation of the Efficacy and Safety of Deflazacort in Stone Clearance after Extracorporeal Shockwave Lithotripsy when used along with Oral Hydration and Alpha Blockers â?? A Randomized Clinical Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/035475

Enrollment

Registered

2021-08-06

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

Intervention1: Deflazacort oral hydration and Tamsulosin: combination of Deflazacort 30mg and Tamsulosin 0.4 mg is taken per orally at bed time for 10 days along with 3 liters of water per day. Contro

Eligibility

Inclusion criteria

Inclusion criteria: All adult patients with uroliathiasis planned for extracorporeal shock wave lithotripsy except the exclusion criteria.

Exclusion criteria

Exclusion criteria: Anatomical abnormality Uncontrolled Coagulopathy Untreated UTI Previous renal/ ureteric surgery Ipsilateral ureteric calculus Renal insufficiency Sr.Creatinine >1.8 Cardiac diseases (MI, Arrhythmias, cardiac surgery, IHD) Uncontrolled HTN Morbid Obesity Uncontrolled DM Immunocomprimised Patients Pregnant women

Design outcomes

Primary

Measure	Time frame
Stone Clearance- Complete/partial Timepoint: 2 weeks after extracorporeal shockwave lithotripsy and given medication	—

Secondary

Measure	Time frame
location of stone in case of partial clearanceTimepoint: 2 weeks after extracorporeal shockwave lithotripsy and given medication;symptoms - pain and hematuriaTimepoint: 2 weeks after extracorporeal shockwave lithotripsy and given medication	—

Countries

India

Contacts

Public ContactDr Senthil Kumar T

SRM Medical College Hospital and Research Institute

drsenku12101978@gmail.com9444226422

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026